Transdiagnostic Online CBT Vs. Care As Usual for Primary Care Patients with Subsyndromal Mental Ill-health ( PRIMARITA-2 )
PRIMARITA-2
Internet-based Transdiagnostic Cognitive Behavior Therapy and Care As Usual for Primary Care Patients with Mental Ill-health (RCT-2: Subsyndromal Mental Ill-health)
1 other identifier
interventional
500
1 country
1
Brief Summary
The goal of this randomized controlled trial is to investigate if online transdiagnostic cognitive behavior therapy (CBT) can be effective in the treatment of subsyndromal mental ill-health in adult primary care patients. The main aim is to investigate: if online transdiagnostic CBT yields superior symptomatic improvement compared to care-as-usual when given in a primary care context to patients with mental ill-health. Researchers will compare online transdiagnostic CBT to primary care as usual to see if psychiatric symptoms can be reduced. Participants will be randomized to online transdiagnostic CBT or primary care as usual. Participants in online transdiagnostic CBT will receive a cognitive behavioral treatment provided through a secure web platform in which psychoeducation, worksheets, and exercises are presented in online modules similar to chapters in a book. Participants will receive weekly written feedback on their work and progress by a therapist who gives gradual access to the treatment modules. The lion's share of the contact between the therapist and the patient thus takes place through messages (similar to email) in the online treatment platform. Participants randomized to care as usual will receive health care services as usual in primary care. As this comparator is intended to reflect real routine primary care, the interventions will not be controlled by the research project, but the investigators expect that participants will receive an active treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedStudy Start
First participant enrolled
February 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 6, 2029
March 7, 2025
February 1, 2025
4 years
January 28, 2025
March 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in Depression Anxiety Stress Scales-21 (DASS-21) to 10-week, and 1-and 2- year follow-ups
This is a 21-item scale with a sum score range 0 to 126 where a higher score indicates more symptoms.
Baseline, weeks 2, 4, 6, 8, 10 (primary endpoint), and 1-and 2-year follow-up
Secondary Outcomes (5)
Change in WHODAS from baseline to 10-week, and 1- and 2-year follow-ups
Baseline, week 10, 1- and 2-year follow-ups
Change in Work Ability Index from baseline to 10-week, and 1- and 2-year follow-ups
Baseline, week 10, 1- and 2-year follow-ups
Change in Brunnsviken Brief Quality of Life Index from baseline to 10-week, and 1- and 2-year follow-ups
Baseline, week 10, 1- and 2-year follow-ups
Change in sickness absence from 1 year before baseline to 1- and 2-year follow-ups
The 1-year period preceding baseline, 1- and 2-year periods after baseline
Change in EPQR-A Neuroticism scale from baseline to 10-week, and 1-and 2-year follow-ups
Baseline, week 10, 1- and 2-year follow-ups
Other Outcomes (11)
Client Satisfaction Questionnaire at 10-week follow-up
10-week follow-up
Negative Effects Questionnaire at 10-week follow-up
10-week follow-up
Credibility Scale (C-scale) 2 weeks after baseline
2 weeks after baseline
- +8 more other outcomes
Study Arms (2)
Online transdiagnostic CBT
EXPERIMENTALParticipants randomized to this arm will receive the intervention online transdiagnostic CBT (see Interventions).
Primary care as usual
ACTIVE COMPARATORPatients randomized to this study condition will receive health care services as usual in primary care.
Interventions
This treatment is provided through a secure web platform in which psychoeducation, worksheets, and exercises are presented in online modules similar to chapters in a book. Participants will receive weekly written feedback on their work and progress by a therapist who gives gradual access to the treatment modules. The lion's share of the contact between the therapist and the patient thus takes place through messages (similar to email) in the online treatment platform. It is however allowed to also have one to three face-to-face sessions on-site or through video calls to provide technical assistance and therapeutic support in accordance with the treatment model. Core components are: (a) psychoeducation about emotions and CBT, (b) functional analysis, (c) mindfulness practice, (d) breaking dysfunctional emotion-driven behaviors, and (e) exposure exercises.
It is mandatory for primary care services in Stockholm, Sweden, to have staff with adequate competence in the assessment and treatment of common mental disorders. Typically, these patients are handled by general practitioners, psychologists, nurses, or social workers. As this comparator is intended to reflect real routine primary care, the interventions will not be controlled by the research project. We expect that participants allocated to this condition will receive an active treatment.
Eligibility Criteria
You may qualify if:
- To be included patients have to:
- To be included patients have to: (a) have a subsyndromal mental health problem concerning anxiety, depressive symptoms, or stress-related ill-health that warrants treatment,
- be at least 18 years old,
- have regular access to a device with an Internet connection,
- be able to read and write in Swedish,
- have no severe psychiatric disorder that requires specialized psychiatric care, such as psychosis, bipolar disorder, or anorexia nervosa,
- if on medication with monoamine agonist, have stable dosage in the past month,
- have no on-going psychological treatment, and
- provide written informed consent for participation and complete baseline assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Region Stockholmcollaborator
Study Sites (1)
Region Stockholm, Gustavsberg Primary Care Center
Gustavsberg, Stockholm County, 134 40, Sweden
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erik Hedman-Lagerlöf, PhD, professor
Region Stockholm and Karolinska Institutet
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, PhD
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 3, 2025
Study Start
February 25, 2025
Primary Completion (Estimated)
February 6, 2029
Study Completion (Estimated)
February 6, 2029
Last Updated
March 7, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
The information collected in the study contains sensitive personal data and is protected by Swedish and European data secrecy regulations. Any data sharing is thus subject to assessment by relevant authorities and is not something the principal investigator can decide upon.